RecruitingNot ApplicableNCT07085754

Effects of Acute Sleep Deprivation on Individuals With Different APOE Genotypes


Sponsor

Yuhui Qiu

Enrollment

60 participants

Start Date

Aug 8, 2025

Study Type

INTERVENTIONAL

Conditions

Summary

This study aims to investigate the effects of 24-hour acute sleep deprivation on plasma Alzheimer's disease biomarkers and multi-omics in individuals with different APOE genotypes, to elucidate the potential role of acute sleep deprivation in AD risk.


Eligibility

Min Age: 18 YearsMax Age: 40 Years

Plain Language Summary

Simplified for easier understanding

This study is investigating how 24 hours without sleep affects blood markers associated with Alzheimer's disease risk in healthy young adults, and whether this effect differs based on a person's APOE gene type (a genetic factor linked to Alzheimer's risk). Understanding how sleep loss influences these biomarkers may shed light on the connection between poor sleep and dementia risk. You may be eligible if you are 18 to 40 years old, healthy and on no medications, sleep 7 to 9 hours per night with good sleep quality, and score above 28 on a standard cognitive screening test. Participation involves one night of total sleep deprivation under supervised conditions, with blood samples collected before and after. This summary was prepared using AI to help patients understand this research.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

BEHAVIORALSleep Deprivation

Sleep deprivation for up to 24 hours with no naps or other sleep periods


Locations(1)

Guangdong Provincial Hospital of Chinese Medicine

Guangzhou, Guangdong, China

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07085754


Related Trials